Page last updated: 2024-08-24

atorvastatin and Dengue

atorvastatin has been researched along with Dengue in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ganesh, K; Kumar, A; Manoj, H; Murugasamy, V; Muthukumaravel, S; Niranjan, R; Sankari, T; Sunilkumar, A; Vidhyapriya, P1
Cordero-Rivera, CD; De Jesús-González, LA; Del Ángel, RM; Farfan-Morales, CN; Hurtado-Monzón, AM; Jiménez-Camacho, R; Meraz-Ríos, MA; Osuna-Ramos, JF; Palacios-Rápalo, SN; Reyes-Ruiz, JM1

Other Studies

2 other study(ies) available for atorvastatin and Dengue

ArticleYear
Atorvastatin attenuates NS1 (Non-structural protein-1) of dengue type-2 serotype-induced expressions of matrix metalloproteinases in HL-60 cells, differentiated to neutrophils: Implications for the immunopathogenesis of dengue viral disease.
    International immunopharmacology, 2022, Volume: 112

    Topics: Antibodies, Viral; Atorvastatin; Dengue; Dengue Virus; HL-60 Cells; Humans; Interleukin-13; Interleukin-6; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Neutrophils; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor D; Viral Nonstructural Proteins

2022
Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections.
    Viruses, 2023, 06-28, Volume: 15, Issue:7

    Topics: Animals; Antiviral Agents; Atorvastatin; Cholesterol; Dengue; Dengue Virus; Drug Repositioning; Ezetimibe; Flavivirus; Flavivirus Infections; Mice; Zika Virus; Zika Virus Infection

2023